High Content Screening Instrument Market based on Product, Application and End User

1. MarketsandMarkets Presents High Content Screening Instrument Market based on Product, Application and End User https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

2. The report "High Content Screening Market by Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, Service) Application (Primary & Secondary Screening, Toxicity Studies, Target Identification & Validation), End User - Global Forecast to 2022", The global high-content screening market is expected to reach USD 909.0 Million by 2022 from USD 557.1 Million in 2017, at a CAGR of 10.3%. Browse 138 market data tables and 42 figures spread through 166 pages and in-depth TOC on "High Content Screening Market by Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, Service) Application (Primary & Secondary Screening, Toxicity Studies, Target Identification & Validation), End User - Global Forecast to 2022" https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

3. Early buyers will receive 10% customization on this report. https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

4. The global high content screening market is projected to reach USD 909.0 million by 2022 from USD 557.1 million in 2017 at a CAGR of 10.3% from 2017 to 2022. The need for cost containment in pharma R&D, advancements in informatics solutions and imaging instruments, and government funding and venture capital investments across developed markets are the major factors driving the growth of the high-content screening (HCS) market. • High-content screening (HCS) is a method that is used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner. High-content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters. https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

5. Based on product, the global high content screening market is broadly segmented into instruments, consumables, software, services, and accessories. The market for HCS software is expected to grow at the highest CAGR between 2017 and 2022. Among all high content screening products, instrument segment caters to the largest share. The large share of this segment is attributed to advances in instrumentation and automation techniques and high prices of HCS instruments. • The high content screening market in APAC is expected to grow at the highest CAGR during the forecast period. Factors such as increasing drug discovery research, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure are driving the growth of the HCS market in this region. https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

6. Primary and Secondary Screening • The major users of HCS for primary and secondary screening are pharmaceutical and biotechnology companies and CROs involved in the drug discovery process. In recent years, the market has witnessed significant developments involving major players and prominent research institutes focusing on the use of HCS in screening applications. In secondary screening, HCS is used in qualitative assays to exclude the compounds with unintended modes of action.Target Identification and Validation • Target identification and validation is the initial step in the drug discovery process. The benefits of high-content screening are especially relevant in drug discovery. Currently, late-stage failure during drug development can result in significant financial losses for companies. To eliminate this possibility, detailed insights are essential into how a drug or compound acts in a functional context on a cellular pathway. This results in more information and confidence in both hit selection as well as safety & efficacy, prior to lead candidate selection. Thus, target identification is a vital step in the drug discovery process. https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

7. https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.htmlhttps://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

8. Contact Us Contact: Mr. Shelly Singh MarketsandMarkets™ INC.630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email:sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/high-content-screening-market.asp Visit Our Website:https://www.marketsandmarkets.com https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

9. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html